AstraZeneca continues yard-sale strategy with $538M Seroquel rights deal

8th May 2018 Uncategorised 0

AstraZeneca is back at it again with its asset sales. The company offloaded certain Seroquel rights to Luye Pharma for up to $538 million.

More: AstraZeneca continues yard-sale strategy with 8M Seroquel rights deal
Source: fierce